NEW YORK (Reuters Health) – Residents and workers exposed to dust after the 9/11 attack on the World Trade Center (WTC) manifest signs of regional distal airways dysfunction,…
NEW YORK (Reuters Health) – A new population-based study finds the incidence of pulmonary complications associated with amiodarone to be relatively low, but still 50% higher among patients…
NEW YORK (Reuters Health) – Bronchodilation is well maintained in patients with chronic obstructive pulmonary disease (COPD) using the long-acting beta-2-agonist indacaterol during 1 year of treatment, investigators…
NEW YORK (Reuters Health) – For patients with severe uncontrolled asthma, adding inhaled tiotropium to standard treatment improves lung function significantly, according to a study published June 3rd…
NEW YORK (Reuters Health) – Patients with moderate-to-severe chronic obstructive pulmonary disease have a greater improvement in dyspnea and health status after 12 weeks of treatment with inhaled…
NEW YORK (Reuters Health) – The longitudinal decline in lung function seen in patients with common variable immunodeficiency and X-linked agammaglobulinemia is related to immunoglobulin replacement level and…
NEW YORK (Reuters Health) – The use of inhaled anticholinergic drugs to treat chronic obstructive pulmonary disease (COPD) is associated with an increased risk of developing urinary retention…
NEW YORK (Reuters Health) – In terms of quality of life for patients with COPD, the improvements in lung function and exacerbation frequency produced by phosphodiesterase 4 (PDE4)…
NEW YORK (Reuters Health) – Older people with chronic obstructive pulmonary disease may live longer if started on an inhaled long-acting beta-agonist than an inhaled long-acting anticholinergic, Canadian…
NEW YORK (Reuters Health) – Omalizumab may improve symptoms in people with severe allergic asthma that is not controlled by corticosteroids and beta-agonists, suggests a new study supported…